Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use
US11787830B2 · kind B2 · utility
2Cited by
26References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 31, 2023 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Mar 31, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to crystalline solids comprising a compound of Formula (I), wherein R is n-propyl, and methods of making compounds of Formula (I) wherein R is C1-C4 alkyl or C2-C4 alkenyl. The present disclosure also relates to crystalline solids comprising a compound of Formula (II), The present disclosure further relates to methods of preparing the crystalline solids, and pharmaceutical preparations of the crystalline solids, and use of such pharmaceutical preparations in treatment of diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.